Cargando…

Trodusquemine displaces protein misfolded oligomers from cell membranes and abrogates their cytotoxicity through a generic mechanism

The onset and progression of numerous protein misfolding diseases are associated with the presence of oligomers formed during the aberrant aggregation of several different proteins, including amyloid-β (Aβ) in Alzheimer’s disease and α-synuclein (αS) in Parkinson’s disease. These small, soluble aggr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Limbocker, Ryan, Mannini, Benedetta, Ruggeri, Francesco S., Cascella, Roberta, Xu, Catherine K., Perni, Michele, Chia, Sean, Chen, Serene W., Habchi, Johnny, Bigi, Alessandra, Kreiser, Ryan P., Wright, Aidan K., Albright, J. Alex, Kartanas, Tadas, Kumita, Janet R., Cremades, Nunilo, Zasloff, Michael, Cecchi, Cristina, Knowles, Tuomas P. J., Chiti, Fabrizio, Vendruscolo, Michele, Dobson, Christopher M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426408/ https://www.ncbi.nlm.nih.gov/pubmed/32792544 http://dx.doi.org/10.1038/s42003-020-01140-8

Ejemplares similares

Characterization of Pairs of Toxic and Nontoxic Misfolded Protein Oligomers Elucidates the Structural Determinants of Oligomer Toxicity in Protein Misfolding Diseases
por: Limbocker, Ryan, et al.
Publicado: (2023)

Trodusquemine enhances Aβ(42) aggregation but suppresses its toxicity by displacing oligomers from cell membranes
por: Limbocker, Ryan, et al.
Publicado: (2019)

Quantitative Measurement of the Affinity of Toxic and Nontoxic Misfolded Protein Oligomers for Lipid Bilayers and of its Modulation by Lipid Composition and Trodusquemine
por: Errico, Silvia, et al.
Publicado: (2021)

Exogenous misfolded protein oligomers can cross the intestinal barrier and cause a disease phenotype in C. elegans
por: Perni, Michele, et al.
Publicado: (2021)

Squalamine and Its Derivatives Modulate the Aggregation of Amyloid-β and α-Synuclein and Suppress the Toxicity of Their Oligomers
por: Limbocker, Ryan, et al.
Publicado: (2021)

Therapeutic Strategies to Reduce the Toxicity of Misfolded Protein Oligomers
por: Kreiser, Ryan P., et al.
Publicado: (2020)

Rationally Designed Antibodies as Research Tools to Study the Structure–Toxicity Relationship of Amyloid-β Oligomers
por: Limbocker, Ryan, et al.
Publicado: (2020)

Two human metabolites rescue a C. elegans model of Alzheimer’s disease via a cytosolic unfolded protein response
por: Joshi, Priyanka, et al.
Publicado: (2021)

Publisher Correction: Two human metabolites rescue a C. elegans model of Alzheimer’s disease via a cytosolic unfolded protein response
por: Joshi, Priyanka, et al.
Publicado: (2021)

Combinations of Vitamin A and Vitamin E Metabolites Confer Resilience against Amyloid-β Aggregation
por: Joshi, Priyanka, et al.
Publicado: (2023)

Studying the trafficking of labeled trodusquemine and its application as nerve marker for light‐sheet and expansion microscopy
por: Capitini, Claudia, et al.
Publicado: (2022)

Distinct responses of human peripheral blood cells to different misfolded protein oligomers
por: Leal‐Lasarte, Magdalena, et al.
Publicado: (2021)

The release of toxic oligomers from α-synuclein fibrils induces dysfunction in neuronal cells
por: Cascella, Roberta, et al.
Publicado: (2021)

Misfolded protein oligomers induce an increase of intracellular Ca(2+) causing an escalation of reactive oxidative species
por: Fani, Giulia, et al.
Publicado: (2022)

Chaperones as Suppressors of Protein Misfolded Oligomer Toxicity
por: Mannini, Benedetta, et al.
Publicado: (2017)

Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies
por: Cascella, Roberta, et al.
Publicado: (2022)

Probing the Origin of the Toxicity of Oligomeric Aggregates of α-Synuclein with Antibodies
por: Cascella, Roberta, et al.
Publicado: (2019)

Microfluidic deposition for resolving single-molecule protein architecture and heterogeneity
por: Ruggeri, Francesco Simone, et al.
Publicado: (2018)

SAR by kinetics for drug discovery in protein misfolding diseases
por: Chia, Sean, et al.
Publicado: (2018)

Rational design of a conformation-specific antibody for the quantification of Aβ oligomers
por: Aprile, Francesco A., et al.
Publicado: (2020)

Lipid Homeostasis and Its Links With Protein Misfolding Diseases
por: Vendruscolo, Michele
Publicado: (2022)

A Brain-Permeable Aminosterol Regulates Cell Membranes to Mitigate the Toxicity of Diverse Pore-Forming Agents
por: Kreiser, Ryan P., et al.
Publicado: (2022)

Aβ Oligomers Dysregulate Calcium Homeostasis by Mechanosensitive Activation of AMPA and NMDA Receptors
por: Fani, Giulia, et al.
Publicado: (2021)

A rationally designed bicyclic peptide remodels Aβ42 aggregation in vitro and reduces its toxicity in a worm model of Alzheimer’s disease
por: Ikenoue, Tatsuya, et al.
Publicado: (2020)

Quantitative Attribution of the Protective Effects of Aminosterols against Protein Aggregates to Their Chemical Structures and Ability to Modulate Biological Membranes
por: Errico, Silvia, et al.
Publicado: (2023)

A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers
por: Cataldi, Rodrigo, et al.
Publicado: (2021)

Publisher Correction: A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers
por: Cataldi, Rodrigo, et al.
Publicado: (2021)

The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity
por: Xu, Catherine K., et al.
Publicado: (2022)

Delivery of Native Proteins into C. elegans Using a Transduction Protocol Based on Lipid Vesicles
por: Perni, Michele, et al.
Publicado: (2017)

From Marine Metabolites to the Drugs of the Future: Squalamine, Trodusquemine, Their Steroid and Triterpene Analogues †
por: Kazakova, Oxana, et al.
Publicado: (2022)

Small-molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer’s disease
por: Heller, Gabriella T., et al.
Publicado: (2020)

Transthyretin Inhibits Primary and Secondary Nucleations of Amyloid-β Peptide Aggregation and Reduces the Toxicity of Its Oligomers
por: Ghadami, Seyyed Abolghasem, et al.
Publicado: (2020)

Abrogation of self-tolerance by misfolded self-antigens complexed with MHC class II molecules
por: Jin, Hui, et al.
Publicado: (2022)

Bacterial production and direct functional screening of expanded molecular libraries for discovering inhibitors of protein aggregation
por: Delivoria, Dafni C., et al.
Publicado: (2019)

Enhanced surface nanoanalytics of transient biomolecular processes
por: Miller, Alyssa, et al.
Publicado: (2023)

Binding affinity of amyloid oligomers to cellular membranes is a generic indicator of cellular dysfunction in protein misfolding diseases
por: Evangelisti, Elisa, et al.
Publicado: (2016)

Comparative Studies in the A30P and A53T α-Synuclein C. elegans Strains to Investigate the Molecular Origins of Parkinson's Disease
por: Perni, Michele, et al.
Publicado: (2021)

Can Allostery Be a Key Strategy for Targeting PTP1B in Drug Discovery? A Lesson from Trodusquemine
por: Maccari, Rosanna, et al.
Publicado: (2023)

TDP-43 Inclusion Bodies Formed in Bacteria Are Structurally Amorphous, Non-Amyloid and Inherently Toxic to Neuroblastoma Cells
por: Capitini, Claudia, et al.
Publicado: (2014)

Partial Failure of Proteostasis Systems Counteracting TDP-43 Aggregates in Neurodegenerative Diseases
por: Cascella, Roberta, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qmtb57bgglk8ad2050trl82efn